Capital Asset Pricing Model (CAPM)
Capital asset pricing model (CAPM) indicates what should be the expected or required rate of return on risky assets like Abbott Laboratories common stock.
Paying user area
Try for free
Abbott Laboratories pages available for free this week:
- Balance Sheet: Assets
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Profitability Ratios
- Enterprise Value to FCFF (EV/FCFF)
- Present Value of Free Cash Flow to Equity (FCFE)
- Net Profit Margin since 2005
- Return on Assets (ROA) since 2005
- Total Asset Turnover since 2005
- Price to Earnings (P/E) since 2005
- Price to Sales (P/S) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Abbott Laboratories for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Rates of Return
Abbott Laboratories, monthly rates of return
| Abbott Laboratories (ABT) | Standard & Poor’s 500 (S&P 500) | |||||
|---|---|---|---|---|---|---|
| t | Date | PriceABT,t1 | DividendABT,t1 | RABT,t2 | PriceS&P 500,t | RS&P 500,t3 |
| Jan 31, 2020 | ||||||
| 1. | Feb 29, 2020 | |||||
| 2. | Mar 31, 2020 | |||||
| 3. | Apr 30, 2020 | |||||
| . | . | . | . | . | . | . |
| . | . | . | . | . | . | . |
| . | . | . | . | . | . | . |
| 58. | Nov 30, 2024 | |||||
| 59. | Dec 31, 2024 | |||||
| Average (R): | ||||||
| Standard deviation: | ||||||
| Abbott Laboratories (ABT) | Standard & Poor’s 500 (S&P 500) | |||||
|---|---|---|---|---|---|---|
| t | Date | PriceABT,t1 | DividendABT,t1 | RABT,t2 | PriceS&P 500,t | RS&P 500,t3 |
| Jan 31, 2020 | ||||||
| 1. | Feb 29, 2020 | |||||
| 2. | Mar 31, 2020 | |||||
| 3. | Apr 30, 2020 | |||||
| 4. | May 31, 2020 | |||||
| 5. | Jun 30, 2020 | |||||
| 6. | Jul 31, 2020 | |||||
| 7. | Aug 31, 2020 | |||||
| 8. | Sep 30, 2020 | |||||
| 9. | Oct 31, 2020 | |||||
| 10. | Nov 30, 2020 | |||||
| 11. | Dec 31, 2020 | |||||
| 12. | Jan 31, 2021 | |||||
| 13. | Feb 28, 2021 | |||||
| 14. | Mar 31, 2021 | |||||
| 15. | Apr 30, 2021 | |||||
| 16. | May 31, 2021 | |||||
| 17. | Jun 30, 2021 | |||||
| 18. | Jul 31, 2021 | |||||
| 19. | Aug 31, 2021 | |||||
| 20. | Sep 30, 2021 | |||||
| 21. | Oct 31, 2021 | |||||
| 22. | Nov 30, 2021 | |||||
| 23. | Dec 31, 2021 | |||||
| 24. | Jan 31, 2022 | |||||
| 25. | Feb 28, 2022 | |||||
| 26. | Mar 31, 2022 | |||||
| 27. | Apr 30, 2022 | |||||
| 28. | May 31, 2022 | |||||
| 29. | Jun 30, 2022 | |||||
| 30. | Jul 31, 2022 | |||||
| 31. | Aug 31, 2022 | |||||
| 32. | Sep 30, 2022 | |||||
| 33. | Oct 31, 2022 | |||||
| 34. | Nov 30, 2022 | |||||
| 35. | Dec 31, 2022 | |||||
| 36. | Jan 31, 2023 | |||||
| 37. | Feb 28, 2023 | |||||
| 38. | Mar 31, 2023 | |||||
| 39. | Apr 30, 2023 | |||||
| 40. | May 31, 2023 | |||||
| 41. | Jun 30, 2023 | |||||
| 42. | Jul 31, 2023 | |||||
| 43. | Aug 31, 2023 | |||||
| 44. | Sep 30, 2023 | |||||
| 45. | Oct 31, 2023 | |||||
| 46. | Nov 30, 2023 | |||||
| 47. | Dec 31, 2023 | |||||
| 48. | Jan 31, 2024 | |||||
| 49. | Feb 29, 2024 | |||||
| 50. | Mar 31, 2024 | |||||
| 51. | Apr 30, 2024 | |||||
| 52. | May 31, 2024 | |||||
| 53. | Jun 30, 2024 | |||||
| 54. | Jul 31, 2024 | |||||
| 55. | Aug 31, 2024 | |||||
| 56. | Sep 30, 2024 | |||||
| 57. | Oct 31, 2024 | |||||
| 58. | Nov 30, 2024 | |||||
| 59. | Dec 31, 2024 | |||||
| Average (R): | ||||||
| Standard deviation: | ||||||
Show all
1 Data in US$ per share of common stock, adjusted for splits and stock dividends.
2 Rate of return on common stock of ABT during period t
3 Rate of return on S&P 500 (the market portfolio proxy) during period t
Variance and Covariance
Abbott Laboratories, calculation of variance and covariance of returns
| t | Date | RABT,t | RS&P 500,t | (RABT,t–RABT)2 | (RS&P 500,t–RS&P 500)2 | (RABT,t–RABT)×(RS&P 500,t–RS&P 500) |
|---|---|---|---|---|---|---|
| 1. | Feb 29, 2020 | |||||
| 2. | Mar 31, 2020 | |||||
| 3. | Apr 30, 2020 | |||||
| . | . | . | . | . | . | . |
| . | . | . | . | . | . | . |
| . | . | . | . | . | . | . |
| 58. | Nov 30, 2024 | |||||
| 59. | Dec 31, 2024 | |||||
| Total (Σ): | ||||||
| t | Date | RABT,t | RS&P 500,t | (RABT,t–RABT)2 | (RS&P 500,t–RS&P 500)2 | (RABT,t–RABT)×(RS&P 500,t–RS&P 500) |
|---|---|---|---|---|---|---|
| 1. | Feb 29, 2020 | |||||
| 2. | Mar 31, 2020 | |||||
| 3. | Apr 30, 2020 | |||||
| 4. | May 31, 2020 | |||||
| 5. | Jun 30, 2020 | |||||
| 6. | Jul 31, 2020 | |||||
| 7. | Aug 31, 2020 | |||||
| 8. | Sep 30, 2020 | |||||
| 9. | Oct 31, 2020 | |||||
| 10. | Nov 30, 2020 | |||||
| 11. | Dec 31, 2020 | |||||
| 12. | Jan 31, 2021 | |||||
| 13. | Feb 28, 2021 | |||||
| 14. | Mar 31, 2021 | |||||
| 15. | Apr 30, 2021 | |||||
| 16. | May 31, 2021 | |||||
| 17. | Jun 30, 2021 | |||||
| 18. | Jul 31, 2021 | |||||
| 19. | Aug 31, 2021 | |||||
| 20. | Sep 30, 2021 | |||||
| 21. | Oct 31, 2021 | |||||
| 22. | Nov 30, 2021 | |||||
| 23. | Dec 31, 2021 | |||||
| 24. | Jan 31, 2022 | |||||
| 25. | Feb 28, 2022 | |||||
| 26. | Mar 31, 2022 | |||||
| 27. | Apr 30, 2022 | |||||
| 28. | May 31, 2022 | |||||
| 29. | Jun 30, 2022 | |||||
| 30. | Jul 31, 2022 | |||||
| 31. | Aug 31, 2022 | |||||
| 32. | Sep 30, 2022 | |||||
| 33. | Oct 31, 2022 | |||||
| 34. | Nov 30, 2022 | |||||
| 35. | Dec 31, 2022 | |||||
| 36. | Jan 31, 2023 | |||||
| 37. | Feb 28, 2023 | |||||
| 38. | Mar 31, 2023 | |||||
| 39. | Apr 30, 2023 | |||||
| 40. | May 31, 2023 | |||||
| 41. | Jun 30, 2023 | |||||
| 42. | Jul 31, 2023 | |||||
| 43. | Aug 31, 2023 | |||||
| 44. | Sep 30, 2023 | |||||
| 45. | Oct 31, 2023 | |||||
| 46. | Nov 30, 2023 | |||||
| 47. | Dec 31, 2023 | |||||
| 48. | Jan 31, 2024 | |||||
| 49. | Feb 29, 2024 | |||||
| 50. | Mar 31, 2024 | |||||
| 51. | Apr 30, 2024 | |||||
| 52. | May 31, 2024 | |||||
| 53. | Jun 30, 2024 | |||||
| 54. | Jul 31, 2024 | |||||
| 55. | Aug 31, 2024 | |||||
| 56. | Sep 30, 2024 | |||||
| 57. | Oct 31, 2024 | |||||
| 58. | Nov 30, 2024 | |||||
| 59. | Dec 31, 2024 | |||||
| Total (Σ): | ||||||
Show all
VarianceABT = Σ(RABT,t–RABT)2 ÷ (59 – 1)
= ÷ (59 – 1)
=
VarianceS&P 500 = Σ(RS&P 500,t–RS&P 500)2 ÷ (59 – 1)
= ÷ (59 – 1)
=
CovarianceABT, S&P 500 = Σ(RABT,t–RABT)×(RS&P 500,t–RS&P 500) ÷ (59 – 1)
= ÷ (59 – 1)
=
Systematic Risk (β) Estimation
| VarianceABT | |
| VarianceS&P 500 | |
| CovarianceABT, S&P 500 | |
| Correlation coefficientABT, S&P 5001 | |
| βABT2 | |
| αABT3 |
Calculations
1 Correlation coefficientABT, S&P 500
= CovarianceABT, S&P 500 ÷ (Standard deviationABT × Standard deviationS&P 500)
= ÷ ( × )
=
2 βABT
= CovarianceABT, S&P 500 ÷ VarianceS&P 500
= ÷
=
3 αABT
= AverageABT – βABT × AverageS&P 500
= – ×
=
Expected Rate of Return
| Assumptions | ||
| Rate of return on LT Treasury Composite1 | RF | |
| Expected rate of return on market portfolio2 | E(RM) | |
| Systematic risk (β) of Abbott Laboratories common stock | βABT | |
| Expected rate of return on Abbott Laboratories common stock3 | E(RABT) | |
1 Unweighted average of bid yields on all outstanding fixed-coupon U.S. Treasury bonds neither due or callable in less than 10 years (risk-free rate of return proxy).
3 E(RABT) = RF + βABT [E(RM) – RF]
= + [ – ]
=